# Efficacy and Safety of Once-Weekly Dulaglutide Versus Insulin Glargine in Patients With Type 2 Diabetes on Metformin and Glimepiride (AWARD-2)

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/efficacy-and-safety-of-once-weekly-dulaglutide-versus-insulin-glargine-in/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Francesco Giorgino,Marian Benroubi,Jui‐Hung Sun,Alan G. Zimmermann,V. Pechtner |
| Citations | 263 |
| DOI | 10.2337/dc14-1625 |
| Fields | Medicine |
| Open Access | true |
| OA Status | green |
| OA URL | http://hdl.handle.net/11586/170428 |
| OpenAlex ID | https://openalex.org/W906438903 |
| PMID | 26089386 |
| Type | article |
| Year | 2015 |

## Paper authors

- [Jui‐Hung Sun](https://scholariq.org/researchers/jui-hung-sun/)
- [Alan G. Zimmermann](https://scholariq.org/researchers/alan-g-zimmermann/)

## Paper journal

- [Diabetes Care](https://scholariq.org/journals/diabetes-care/)

## Paper primary topic

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)

## Paper topics

- [Diabetes Treatment and Management](https://scholariq.org/topics/diabetes-treatment-and-management/)
- [Diabetes Management and Research](https://scholariq.org/topics/diabetes-management-and-research/)
- [Bariatric Surgery and Outcomes](https://scholariq.org/topics/bariatric-surgery-and-outcomes/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.